Clinical Trial

A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is still being tested in studies and is not yet available for prescription by doctors. In this study, participants will receive either NNC6989-0001 or a placebo; which treatment each participant receives will be decided by chance.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-07-30
notable Enrollment increased: 96 -> 132 participants 2026-07-30
Trial Details
NCT Number NCT07437079
Lead Sponsor Novo Nordisk A/S
Conditions Overweight, Obesity
Enrollment 132 participants
Start Date 2026-02-24
Primary Completion 2027-01-21 (estimated)
Study Completion 2027-01-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-29